NRX Pharmaceuticals, Inc. — Form D
NRX Pharmaceuticals, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-22. The offering totals $2.8M, of which $2.5M was reported sold. Industry: Commercial.
Offering
- Filed: 2017-11-22
- Form: D
- Accession: 0001719406-17-000001
- Industry: Commercial
- Exemptions: 06b
- Total offering: $2.8M
- Amount sold: $2.5M
- Remaining: $225K
- Minimum investment: $25K
- Investors: 1
- Date of first sale: 2017-09-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-299427
Issuer
- Name: NRX Pharmaceuticals, Inc.
- CIK: 0001719406
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1201 ORANGE STREET, WILMINGTON, DE, 19801
- Phone: 484-254-6134
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Richard Ackerman | Director | Delray Beach, FL |
| Richard B Bardoff | Director | Delray Beach, FL |
| Michael B Fong | Director | Delray Beach, FL |
| Stuart F Koenig | Director | Delray Beach, FL |
| Albert G Rex | Director | Delray Beach, FL |
| Troy T Taylor | Director | Delray Beach, FL |
| Lori B Wittman | Director | Las Vegas, NV |
| Richard Ackerman | Executive Officer | Delray Beach, FL |
| Kim B Bennett | Executive Officer | Delray Beach, FL |
| Lori B Wittman | Executive Officer | Las Vegas, NV |
| Patrick Flynn | Director | Cambridge, MA |
| Michael Taylor | Director | Westlake Village, CA |
| Michael Abrams | Executive Officer | Wilmington, DE |
| Jonathan Javitt | Director | Bethesda, MD |
| Jonathan Javitt | Executive Officer | Bethesda, MD |
| Chaim Hurvitz | Director | Wilmington, DE |
| Dennis McBride | Director | Wilmington, DE |
Other filings by this issuer (1)
More